,
Wong, Angel Y. S. https://orcid.org/0000-0002-8618-7333
Tomlinson, Laurie A.
Brown, Jeremy P.
Elson, William
Walker, Alex J.
Schultze, Anna
Morton, Caroline E.
Evans, David
Inglesby, Peter
MacKenna, Brian
Bhaskaran, Krishnan
Rentsch, Christopher T.
Powell, Emma
Williamson, Elizabeth
Croker, Richard
Bacon, Seb
Hulme, William
Bates, Chris
Curtis, Helen J.
Mehrkar, Amir
Cockburn, Jonathan
McDonald, Helen I.
Mathur, Rohini
Wing, Kevin
Forbes, Harriet
Eggo, Rosalind M.
Evans, Stephen J. W.
Smeeth, Liam
Goldacre, Ben
Douglas, Ian J.
Funding for this research was provided by:
Medical Research Council (MR/V015737/1)
Article History
Received: 12 August 2021
Accepted: 4 October 2021
First Online: 19 October 2021
Declarations
:
: This study was approved by the Health Research Authority (REC reference 20/LO/0651) and by the LSHTM Ethics Board (reference 21863).
: Not applicable.
: All authors have completed the ICMJE uniform disclosure form at and declare the following: BG has received research funding from Health Data Research UK (HDRUK), the Laura and John Arnold Foundation, the Wellcome Trust, the NIHR Oxford Biomedical Research Centre, the NHS National Institute for Health Research School of Primary Care Research, the Mohn-Westlake Foundation, the Good Thinking Foundation, the Health Foundation, and the World Health Organisation; he also receives personal income from speaking and writing for lay audiences on the misuse of science. IJD has received unrestricted research grants and holds shares in GlaxoSmithKline (GSK).
: NHS England is the data controller; TPP is the data processor; and the key researchers on OpenSAFELY are acting on behalf of NHS England. This implementation of OpenSAFELY is hosted within the TPP environment which is accredited to the ISO 27001 information security standard and is NHS IG Toolkit compliant [, ]; patient data have been pseudonymised for analysis and linkage using industry standard cryptographic hashing techniques; all pseudonymised data sets transmitted for linkage onto OpenSAFELY are encrypted; access to the platform is via a virtual private network (VPN) connection, restricted to a small group of researchers, their specific machine and IP address; the researchers hold contracts with NHS England and only access the platform to initiate database queries and statistical models; all database activity is logged; only aggregate statistical outputs leave the platform environment following best practice for anonymisation of results such as statistical disclosure control for low cell counts []. The OpenSAFELY research platform adheres to the data protection principles of the UK Data Protection Act 2018 and the EU General Data Protection Regulation (GDPR) 2016. In March 2020, the Secretary of State for Health and Social Care used powers under the UK Health Service (Control of Patient Information) Regulations 2002 (COPI) to require organisations to process confidential patient information for the purposes of protecting public health, providing healthcare services to the public and monitoring and managing the COVID-19 outbreak and incidents of exposure []. Taken together, these provide the legal bases to link patient data sets on the OpenSAFELY platform. GP practices, from which the primary care data are obtained, are required to share relevant health information to support the public health response to the pandemic and have been informed of the OpenSAFELY analytics platform.